Navigation Links
£12 million funding to tackle devastating livestock and poultry viruses
Date:11/19/2012

globally important pathogen"

Tackling Poultry Viruses

Over 6.2M to develop rapid responses to emerging poultry viruses

Over 6.2M BBSRC funding has been awarded to develop rapid responses to emerging poultry viruses. The funding boost will also help to establish the next generation of poultry virologists, to work in a scientific area where the UK has traditionally been strong.

The 'Developing Rapid Responses to Emerging Virus Infections of Poultry' project will enable the recognition of emerging viruses before widespread infections occur, prepare for the possibility of new subtypes of avian influenza, and help the process of developing better vaccines for poultry and humans.

The research will be led by Dr Michael Skinner, (Imperial College London). It will involve close collaboration between Prof Wendy Barclay (also at Imperial College London), Dr Laurence Tiley, Prof Jim Kaufman and Prof Ian Goodfellow (all at the University of Cambridge) and Prof Steve Goodbourn (St George's, University of London), as well as Prof Venugopal Nair (at The Pirbright Institute), who is a visiting professor at Imperial College London, and Prof Helen Sang at the University of Edinburgh's BBSRC-funded Roslin Institute.

This research will address important scientific challenges to allow better isolation and diagnosis of emerging viruses, as well as faster and better production of vaccines against them. Scientists will study endemic and exotic viruses, in an era when new poultry viruses rapidly cross national and continental boundaries to become global problems.

Dr Michael Skinner, Imperial College London, said: "One area of the research will help us to identify infections early. We are looking for distinct signatures that appear upon infection of cells in the lab. We can use these signatures to create means of detecting new viruses, especially in elite breeder flocks, where the UK and Europe has an important global com
'/>"/>

Contact: Rob Dawson
01-794-413-204
Biotechnology and Biological Sciences Research Council
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. NAS receives $350 million endowment from BP settlement with the federal government
2. £60 million boost for science innovation
3. NIH awards Penn scientists $10 million over 5 years for innovative research on single cells
4. £39 million for UK energy efficiency research to cut carbon use
5. Tom Bowman seeks to engage 30 million small businesses in climate response
6. Smithsonian launches global marine biodiversity project with $10 million donation
7. Feinstein Institute receives $1 million grant to study impact of World Trade Center attacks on responders
8. Emory receives $20 million NSF grant for chemistry center
9. Pitt biologist receives $2 million to study genetic diversity of plants worldwide
10. The George Washington University Researcher received $1.7 million to study solar cement
11. Wayne State receives $2.8 million grant from US Administration for Children and Families
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the publication ... 3 study of Zerenex (ferric citrate), the Company,s investigational ... hyperphosphatemia in patients with end-stage renal disease (ESRD) on ... with FErric CiTrate in EsrD) was published online today ... Nephrology ( JASN ). , This ...
(Date:7/24/2014)... Scientists at The New York Stem Cell ... to creating a viable cell replacement therapy for ... , For the first time, NYSCF scientists generated ... samples of patients with primary progressive multiple sclerosis ... induce these stem cells into becoming oligodendrocytes, the ...
(Date:7/24/2014)... have decreased by 45% on average over a 35 ... a study on the impact of humans on declining ... benefits invertebrates such as insects, spiders, crustaceans, slugs and ... pest control for crops, decomposition for nutrient cycling, water ... Science and led by UCL, Stanford and ...
Breaking Biology News(10 mins):Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Invertebrate numbers nearly halve as human population doubles 2Invertebrate numbers nearly halve as human population doubles 3
... gradual extinction of cold-loving species, and the European land ... from the University of Kassel in Germany and the ... that human-induced temperature increases over a 40-year period in ... the near extinction of the local land leech Xerobdella ...
... have long known that the human body runs like clockwork, ... of light and darkness. Now a team of researchers is ... activity, which could allow them to predict optimal timing for ... solar day and relieve psychosocial stress. In short, ...
... showing that dog-walking in bushland significantly reduces bird ... against the practice in sensitive bushland and conservation ... the ecological impacts of dog-walking have remained subjective ... But the first clear evidence that birds ...
Cached Biology News:Role reversal as humans suck life out of leeches 2Researchers developing device to predict proper light exposure for human health 2Researchers developing device to predict proper light exposure for human health 3A dog in the hand scares birds in the bush 2
(Date:7/24/2014)... Research and Markets has announced the addition ... Market 2014-2018" report to their offering. ... the study of the gene and its functions and ... of proteomes or sets of proteins by using molecular ... mapping of genes and DNA sequencing to understand the ...
(Date:7/24/2014)... , July 24, 2014 SRI International ... with the National Institute of Allergy and Infectious Diseases ... conduct preclinical development of potential therapies for HIV infection ... to treat HIV and AIDS and the complications and ... microbicides for preventing sexual transmission of HIV. ...
(Date:7/24/2014)... July 24, 2014 Three companies from ... in Livestrong’s Big C Competition. Out of 700 competition ... headed to the semi-final round. In this round twenty ... accelerator program, complete with mentoring from thought-leaders and medical ... part of the angelMD commitment to the Livestrong vision ...
(Date:7/24/2014)... 2014  Neogen Corporation (Nasdaq: NEOG ) ... potential revenue from new rodenticide research are premature. In ... on July 22, 2014, Neogen,s CEO commented about several ... "It was my intent Tuesday at our ... a new type of rodenticide, but certainly not to ...
Breaking Biology Technology:Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 33 angelMD Startups Make Livestrong Big C Semi-finals 2Neogen comments on SenesTech 2
... 28 , - Guests Will ... , Staying healthy in these stressful ... Attitude Health Retreats early in 2009 may provide,participants with the ... A key component of the retreat ...
... XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB , ... it received a Staff Determination Letter (the "Letter") from ... the staff of Nasdaq,s Listing Qualifications Department determined, using ... the Company,s American Depository Shares ("ADRs") would be delisted ...
... web based CTMS (Clinical Trial Management System), has ... deployed visit reports, site payments, sponsor portal and ... project will include integration to our electronic data ... as other innovative functional changes to the system ...
Cached Biology Technology:New Health Retreat Gives a Fresh Attitude Towards Disease Prevention 2AAIPharma Deploys Clinical Force CTMS (Clinical Trials Management System) 2AAIPharma Deploys Clinical Force CTMS (Clinical Trials Management System) 3
...
...
... White solid. PROTECT FROM LIGHT. ... sulfanamido-benzbromarone compound that acts as a ... of PTP1B (IC 50 = ... PTP1B 403 and PTP1B 298 ...
...
Biology Products: